Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

Tian Zhang, Peiru Chi, Zhiping Fan, Na Xu, Hui Xu, Fen Huang, Ren Lin, Zhixiang Wang, Hui Liu, Xueying Ou, Ke Zhao, Ling Jiang, Jing Sun, Qifa Liu, Li Xuan

Blood (2024) 144 (Supplement 1): 7385.

https://doi.org/10.1182/blood-2024-203334

Published: 2024

Journal Articles

ALDH3A2 Regulates Ferroptosis By Participating in Fatty Acid Synthesis and Finally Lead to Chemotherapy Resistance in Acute Myeloid Leukemia

Yun Huang, Xuejie Jiang, Ling Jiang, Yujiao Zhang, Fang Liu, Ping Yan, Baoyi Yuan, Quan Wu, Yu Zhao

Blood (2023) 142 (Supplement 1): 2935.

https://doi.org/10.1182/blood-2023-174357

Published: 2023

Journal Articles

Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Zhonghui Jiang, Zhiping Fan, Hui Xu, Na Xu, Tian Zhang, Huiwen Xue, Ren Lin, Zhixiang Wang, Ling Jiang, Jing Sun, Li Xuan

Blood (2023) 142 (Supplement 1): 4871.

https://doi.org/10.1182/blood-2023-178337

Published: 2023

Journal Articles

Post-Transplantation Cyclophosphamide Combined with Tacrolimus and Low-Dose Post-Engraftment Anti-Thymoglobulin As Gvhd Prophylaxis for Patients Undergoing Peripheral Blood Stem Cell Transplantation from Haplo Donors: A Single Center Analysis

Jiong Hu, Wenhui GAO, Ming Chen, Li-Ling Wang, Ling Wang, Raynier Devillier, Jie-Ling Jiang, Didier Blaise

Blood (2022) 140 (Supplement 1): 12878–12879.

https://doi.org/10.1182/blood-2022-168484

Published: 2022

Journal Articles

Prophylactic Donor Lymphocyte Infusion Based on Two Different Time for Preventing Relapse in Advanced Acute Leukemia Undergoing Allo-HSCT: Comparison of Two Independent Prospective Cohorts

Qiongqiong Su, Zhiping Fan, MD, Fen Huang, Na Xu, Danian Nie, MD, Dongjun Lin, MD, Ziwen Guo, MD, Shi Pengcheng, Zhixiang Wang, Ling Jiang, Jing Sun, MD, Zujun Jiang, Qifa Liu, MD, Li Xuan, MD

Blood (2020) 136 (Supplement 1): 7–8.

https://doi.org/10.1182/blood-2020-137404

Published: 2020

Journal Articles

Cidofovir, a Choice for Salvage Treatment of CMV Infection in the Patients with Haploidentical Hematopoitic Stem Cell Transplantation

Zhao Yin, Na Xu, Ling Jiang, Pengcheng Shi, Zhiping Fan, MD, Fen Huang, Qifa Liu, MD, Jing Sun, Guopan Yu

Blood (2020) 136 (Supplement 1): 40–41.

https://doi.org/10.1182/blood-2020-138685

Published: 2020

Journal Articles

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD + acute myeloid leukemia

Blood (2020) 135 (17): 1472–1483.

https://doi.org/10.1182/blood.2019003538

Published: 2020

Includes: Supplemental data

Journal Articles

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Guo-Pan Yu, MD, Zhao Yin, Zhiping Fan, Fen Huang, Na Xu, Ling Jiang, Zhixiang Wang, PhD, Li Xuan, MD, Qifa Liu, MD, Ru Feng, MD, Jing Sun

Blood (2019) 134 (Supplement_1): 5659.

https://doi.org/10.1182/blood-2019-126705

Published: 2019

Journal Articles

Influence of FLT3 -ITD Mutation and Length on the Treatment Response and Prognosis in Cytogenetically Normal AML Patients

Xuejie Jiang, MD, Changxin Yin, Junya Sun, Jiaying Cheng, Qiang Wang, Guopan Yu, Ling Jiang, Dan Xu, Xiaoli Liu, Ru Feng, MD, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5245.

https://doi.org/10.1182/blood-2018-99-111063

Published: 2018

Journal Articles

Gene Mutation Profile and Risk Stratification in AML1-ETO-Positive Acute Myeloid Leukemia Based on Next-Generation Sequencing

Guopan Yu, Changxin Yin, Fuqun Wu, Ling Jiang, Zhongxin Zheng, Dan Xu, Jiaheng Zhou, Xuejie Jiang, MD, Qifa Liu, MD, Fanyi Meng

Blood (2018) 132 (Supplement 1): 5249.

https://doi.org/10.1182/blood-2018-99-113494

Published: 2018

Journal Articles

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

Zhiping Fan, MD, Lan Deng, MD PhD, Xudong Li, Qing Zhang, MD, Li Xuan, Fen Huang, Ren Lin, Hua Jin, Na Xu, PhD, Pengcheng Shi, Zhixiang Wang, PhD, Jieyu Ye, Ling Jiang, Jing Sun, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 5724.

https://doi.org/10.1182/blood-2018-99-117430

Published: 2018

Journal Articles

A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Guo-Pan Yu, MD, Changxin Yin, Fuqun Wu, Dan Xu, Zhongxin Zheng, Ling Jiang, PhD MD, Fang Chen, Xuejie Jiang, MD, Qifa Liu, Fanyi Meng

Blood (2017) 130 (Supplement 1): 5088.

https://doi.org/10.1182/blood.V130.Suppl_1.5088.5088

Published: 2017

Journal Articles

Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia

Xuejie Jiang, MD, Fang Chen, Changxin Yin, Ling Jiang, PhD MD, Guo-Pan Yu, MD, Dan Xu, Jing Sun, MD, Xiaoli Liu, MD PhD, Qifa Liu

Blood (2017) 130 (Supplement 1): 5089.

https://doi.org/10.1182/blood.V130.Suppl_1.5089.5089

Published: 2017

Journal Articles

MiR-144 Targets APP to Regulate AML1/ETO+ Leukemia Cell Migration Via p-ERK/c-Myc/MMP-2 Pathway

Fanyi Meng, Ling Jiang, PhD MD, Wei Meng, PhD, Guo-Pan Yu, MD, Yin Changxin, Zhixiang Wang, PhD, Xuejie Jiang, MD, Qifa Liu

Blood (2017) 130 (Supplement 1): 5093.

https://doi.org/10.1182/blood.V130.Suppl_1.5093.5093

Published: 2017

Journal Articles

Berberine Acts As a Putative Epigenetic Modulator By Affecting Histone Code in Acute Myelocytic Leukemia Cells

Zhixiang Wang, PhD, Qifa Liu, Xuejie Jiang, MD, Yu Zhang, PhD, Ling Jiang, PhD MD, Fanyi Meng

Blood (2017) 130 (Supplement 1): 4989.

https://doi.org/10.1182/blood.V130.Suppl_1.4989.4989

Published: 2017

Journal Articles

BM-MSC Hhip Induced Microenvironment Protection from Chemotherapy in AML Via Ptch/Smo/Gli Pathwa

Xuejie Jiang, Dan Xu, Fang Chen, Ling Jiang, Guopan Yu, Fanyi Meng, Xiaoli Liu, PhD, Qifa Liu, MD

Blood (2016) 128 (22): 5235.

https://doi.org/10.1182/blood.V128.22.5235.5235

Published: 2016

Journal Articles

APP Gene Involves in the Regulation of Cell Apoptosis in AML1-ETO-Positive Leukemia Via SCF/c-Kit Signaling Pathway

Guopan Yu, Ling Jiang, Changxin Yin, Zhixiang Wang, Hongsheng Zhou, Xuejie Jiang, Qifa Liu, MD, Fanyi Meng

Blood (2015) 126 (23): 3647.

https://doi.org/10.1182/blood.V126.23.3647.3647

Published: 2015

Journal Articles

APP Gene Is Correlated with C-KIT Mutations and Indicates Poor Disease Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Guopan Yu, MD, Ling Jiang, MDPhD, Fan Yi Meng, MD, Changxin Yin, Zhixiang Wang, MD, Hongsheng Zhou, MDPhD, Xuejie Jiang, MDPhD, Qingxiu Zhong, MD, Rui Cao, Libin Liao

Blood (2014) 124 (21): 942.

https://doi.org/10.1182/blood.V124.21.942.942

Published: 2014

Journal Articles

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

Fan Yi Meng, MD, Ling Jiang, MD PhD, Qingxiu Zhong, MD, Li Chun Wang, MD, Guopan Yu, MD, Xinhua Zhu, MD

Blood (2014) 124 (21): 5953.

https://doi.org/10.1182/blood.V124.21.5953.5953

Published: 2014

Journal Articles

Molecular Mechanism Of Regulation Of Extramedullary Infiltration In AML1/ETO Positive Acute Myeloid Leukemia By APP/ERK/MMP-2

Guopan Yu, MD, Fan Yi Meng, MD, Ling Jiang, MD/PH.D, Changxin Yin, MD, Zhixiang Wang, MD, Hongsheng Zhou, Xuejie Jiang, MD/PH.D, Lingxiu Zhang, MD, Rui Cao, Libin Liao, MB

Blood (2013) 122 (21): 3769.

https://doi.org/10.1182/blood.V122.21.3769.3769

Published: 2013

NARROW

Sorafenib Combined with Chemotherapy and Donor Lymphocyte Infusion for Patients with FLT3 Wild-Type Acute Leukemia Relapsing after Allo-HSCT

ALDH3A2 Regulates Ferroptosis By Participating in Fatty Acid Synthesis and Finally Lead to Chemotherapy Resistance in Acute Myeloid Leukemia

Adoptive Therapy with Cytomegalovirus-Specific Cytotoxic T Lymphocytes for Refractory Cytomegalovirus Infection and Disease after Allogeneic Hematopoietic Stem Cell Transplantation

Post-Transplantation Cyclophosphamide Combined with Tacrolimus and Low-Dose Post-Engraftment Anti-Thymoglobulin As Gvhd Prophylaxis for Patients Undergoing Peripheral Blood Stem Cell Transplantation from Haplo Donors: A Single Center Analysis

Prophylactic Donor Lymphocyte Infusion Based on Two Different Time for Preventing Relapse in Advanced Acute Leukemia Undergoing Allo-HSCT: Comparison of Two Independent Prospective Cohorts

Cidofovir, a Choice for Salvage Treatment of CMV Infection in the Patients with Haploidentical Hematopoitic Stem Cell Transplantation

FLT3 inhibition upregulates HDAC8 via FOXO to inactivate p53 and promote maintenance of FLT3-ITD + acute myeloid leukemia

The Efficacy and Safety of Cidofovir in Salvage Therapy for CMV Infection in the Patients with Haploid Hematopoietic Stem Cell Transplantation

Influence of FLT3 -ITD Mutation and Length on the Treatment Response and Prognosis in Cytogenetically Normal AML Patients

Gene Mutation Profile and Risk Stratification in AML1-ETO-Positive Acute Myeloid Leukemia Based on Next-Generation Sequencing

Efficacy and Safety of Ruxolitinib in Treatment of Steroid Refractory/Refractory Acute Graft-Versus-Host Disease: A Prospective Multicenter Research

A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Influence of FLT3-ITD Mutation and Length on the Prognosis in Acute Myeloid Leukemia

MiR-144 Targets APP to Regulate AML1/ETO+ Leukemia Cell Migration Via p-ERK/c-Myc/MMP-2 Pathway

Berberine Acts As a Putative Epigenetic Modulator By Affecting Histone Code in Acute Myelocytic Leukemia Cells

BM-MSC Hhip Induced Microenvironment Protection from Chemotherapy in AML Via Ptch/Smo/Gli Pathwa

APP Gene Involves in the Regulation of Cell Apoptosis in AML1-ETO-Positive Leukemia Via SCF/c-Kit Signaling Pathway

APP Gene Is Correlated with C-KIT Mutations and Indicates Poor Disease Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Molecular Mechanisms of EML in AML1/ETO+ AML and Its Targeting Treatments

Molecular Mechanism Of Regulation Of Extramedullary Infiltration In AML1/ETO Positive Acute Myeloid Leukemia By APP/ERK/MMP-2

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only